Choksi Laboratories

Home» Pharmaceutical Analysis» Unknown Peak Identification

CLL Workflow for Unknown Peak Identification

Identification of unknown peaks in is now a regulatory requirement. Any unknown peak(s) eluting in LC chromatograms are required to be identified and reviewed to check whether it is API, Excipient or Process related. CLL’s LC-QTOF workflow can make unknown peak identification a breeze.

CLL Workflow for Unknown Peak Identification

Why is unknown impurity identification useful?

Unknown Peak Identification Graph

Advantages of CLL Workflow

  • No MS compatible method
    development needed.
  • CLL will replicate your method on LC using your own sample preparations, mobile phase and column.
  • Saves investigation &
    laboratory time

Information from the CLL’s Standard Unknown Impurity Report?

  • Molecular Chemical Formula
  • Molecular Mass
  • MS and MS2 fragments
  • Probable identification with Structure and stated mass accuracy

Additional Information from CLL’s Advanced Report

  • Product or process related impurity
  • Potential source of impurity determined – placebo, reagents, process carry-over, etc.

Sample Volume Required:

Prepared Blank, Standard and Sample vials (1mL each), Mobile phase (1 – 2 Liters), Placebo (5grams), API (2grams).

Additional information required at time of submission for exact
replication of your method and unknown impurity – Column, Your Chromatogram with unknown peak and API peak marked, Instrument
method, STP and Specification.

Turnaround time: 5 working days; Express 48 hoursservices available.

Scroll to Top